SYROS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.48 USD | -0.54% |
|
+9.38% | -29.65% |
| 14/05 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| 14/05 | Syros Pharmaceuticals, Inc. Agrees to Amend Its Loan Agreement with Oxford Finance LLC | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Other Biotechnology & Medical Research | -0.54% | +9.38% | -29.65% | +43.46% | -91.93% | 15Cr |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- SYRS Stock
- Charts Syros Pharmaceuticals, Inc.
- Comparison Chart
